Worldwide Healthcare Trust


£2108.5m market cap

3510p last close

Worldwide Healthcare Trust’s investment objective is to invest worldwide in pharmaceutical, biotechnology and related securities in the healthcare sector to achieve a high level of capital growth. Gearing and derivative transactions are used to mitigate risk and enhance capital returns.

Investment summary

Worldwide Healthcare Trust (WWH) is celebrating its 25th anniversary. Managed by Sven Borho and Trevor Polischuk at OrbiMed, the trust has an enviable absolute and relative performance track record. The managers remain very constructive on the prospects for the global healthcare sector, suggesting that while President Trump has once again focused on the issue of US drug pricing, his ‘bark is worse than his bite’, and his efforts are a negotiating ploy to get the healthcare industry to the table to discuss reforms. They highlight minimal disruptions at the US Food and Drug Administration (FDA) as a result of the coronavirus, and expect an uptick in industry mergers and acquisitions (M&A) in H220 and beyond.

Register to receive research on Worldwide Healthcare Trust as it is published
Share price graph
Price performance
Actual 0.9 (3.0) 39.3
Relative* 0.2 3.1 69.4
52-week high/low 3690.0p/2210.0p
*% relative to local index
Key management
David Harris Chairman
Martin Smith Chairman
Sven H Borho Fund manager

You may also be interested in…